Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Marfella

Showing results (11-20 of 306) with videos related to

Pageof 31
Sort By:
Circulation|October 26, 2018
Letter by Sardu et al Regarding Article, "Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy"Celestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Cardiovascular Research|September 8, 2025
Microplastics and nanoplastics: tiny threats for cardiovascular diseases?Raffaele Marfella, Francesco Prattichizzo, Giuseppe Paolisso
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Fitness versus fatness: the debate continuesKatherine Esposito, Raffaele Marfella, Dario Giugliano
The American Journal of Cardiology|November 9, 2005
Myocardial infarction and hyperglycemiaRaffaele Marfella, Mario Verza, Ludovico Coppola
Journal of the American College of Cardiology|February 12, 2021
Impact of Sex Differences in Incident and Recurrent Coronary Events and All-Cause MortalityCelestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Archives of Internal Medicine|October 24, 2012
Subclinical hypothyroidism and cardiovascular diseaseRaffaele Marfella, Carlo Carella, Giuseppe Paolisso
Circulation|April 12, 2003
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarctionRaffaele Marfella, Mario Verza, Dario Giugliano
Frontiers in Pharmacology|June 6, 2022
Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic ImplicationsRaffaele Marfella, Massimo Federici, Giuseppe Paolisso
Current Pharmaceutical Design|February 14, 2020
Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic TargetsCelestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Circulation|February 10, 2016
Letter by Sardu et al Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study"Celestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Pageof 31

Showing results (11-20 of 306) with videos related to

Sort By:
Pageof 31
Circulation|October 26, 2018
Letter by Sardu et al Regarding Article, "Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy"Celestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Cardiovascular Research|September 8, 2025
Microplastics and nanoplastics: tiny threats for cardiovascular diseases?Raffaele Marfella, Francesco Prattichizzo, Giuseppe Paolisso
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2005
Fitness versus fatness: the debate continuesKatherine Esposito, Raffaele Marfella, Dario Giugliano
The American Journal of Cardiology|November 9, 2005
Myocardial infarction and hyperglycemiaRaffaele Marfella, Mario Verza, Ludovico Coppola
Journal of the American College of Cardiology|February 12, 2021
Impact of Sex Differences in Incident and Recurrent Coronary Events and All-Cause MortalityCelestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Archives of Internal Medicine|October 24, 2012
Subclinical hypothyroidism and cardiovascular diseaseRaffaele Marfella, Carlo Carella, Giuseppe Paolisso
Circulation|April 12, 2003
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarctionRaffaele Marfella, Mario Verza, Dario Giugliano
Frontiers in Pharmacology|June 6, 2022
Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic ImplicationsRaffaele Marfella, Massimo Federici, Giuseppe Paolisso
Current Pharmaceutical Design|February 14, 2020
Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic TargetsCelestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Circulation|February 10, 2016
Letter by Sardu et al Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study"Celestino Sardu, Giuseppe Paolisso, Raffaele Marfella
Pageof 31